3.08M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair.

Similar securities

Based on sector and market capitalization

Report issue